{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:44:21Z","timestamp":1786985061203,"version":"build-2736575974"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008802","name":"Ministry of Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homoeopathy","doi-asserted-by":"publisher","award":["3-69\/2020-CCRUM\/Tech"],"award-info":[{"award-number":["3-69\/2020-CCRUM\/Tech"]}],"id":[{"id":"10.13039\/501100008802","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","award":["27(0368)\/20\/EMR-II"],"award-info":[{"award-number":["27(0368)\/20\/EMR-II"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100030887","name":"Central Council for Research in Unani Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030887","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002383","name":"King Saud University","doi-asserted-by":"publisher","award":["ORF-2025-122"],"award-info":[{"award-number":["ORF-2025-122"]}],"id":[{"id":"10.13039\/501100002383","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020374","name":"Government of India Ministry of Ayush","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020374","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.bbrc.2025.152166","type":"journal-article","created":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T01:24:02Z","timestamp":1749345842000},"page":"152166","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Structure-guided discovery of tau-phosphorylating kinase DYRK1A inhibitors for therapeutic targeting of neuroinflammatory diseases: Insights from microsecond MD simulation and MMPBSA analyses"],"prefix":"10.1016","volume":"775","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7217-1744","authenticated-orcid":false,"given":"Arunabh","family":"Choudhury","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumaiya","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Umar","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taj","family":"Mohammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afzal","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed F.","family":"AlAjmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4111-3944","authenticated-orcid":false,"given":"Urooj","family":"Fatima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asimul","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3663-4940","authenticated-orcid":false,"given":"Md Imtaiyaz","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2025.152166_bib1","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/B978-0-323-98817-9.00015-6","article-title":"The tauopathies","volume":"196","author":"Devi","year":"2023","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.bbrc.2025.152166_bib2","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s40035-024-00429-6","article-title":"Tau in neurodegenerative diseases: molecular mechanisms, biomarkers, and therapeutic strategies","volume":"13","author":"Zhang","year":"2024","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.bbrc.2025.152166_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.101924","article-title":"Nature's toolbox against tau aggregation: an updated review of current research","volume":"87","author":"Khan","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.bbrc.2025.152166_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2025.102680","article-title":"Understanding of alzheimer's disease pathophysiology for therapeutic implications of natural products as neuroprotective agents","volume":"105","author":"Prabha","year":"2025","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.bbrc.2025.152166_bib5","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1007\/s00415-024-12314-3","article-title":"Genetic forms of tauopathies: inherited causes and implications of Alzheimer's disease-like TAU pathology in primary and secondary tauopathies","volume":"271","author":"Langerscheidt","year":"2024","journal-title":"J. Neurol."},{"key":"10.1016\/j.bbrc.2025.152166_bib6","first-page":"1","article-title":"Tau immunotherapies for Alzheimer's disease and related tauopathies: status of trials and insights from preclinical studies","author":"Sigurdsson","year":"2024","journal-title":"J. Alzheim. Dis."},{"key":"10.1016\/j.bbrc.2025.152166_bib7","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.1002\/alz.13784","article-title":"The six brain\u2010specific TAU isoforms and their role in alzheimer's disease and related neurodegenerative dementia syndromes","volume":"20","author":"Buchholz","year":"2024","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.bbrc.2025.152166_bib8","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.240035","article-title":"Beyond amyloid and tau: rethinking Alzheimer's disease through less explored avenues","volume":"14","author":"Gyimesi","year":"2024","journal-title":"Open Biology"},{"key":"10.1016\/j.bbrc.2025.152166_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102476","article-title":"Recent advancement in understanding of alzheimer's disease: risk factors, subtypes, and drug targets and potential therapeutics","author":"Prabha","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.bbrc.2025.152166_bib10","doi-asserted-by":"crossref","first-page":"25893","DOI":"10.1074\/jbc.273.40.25893","article-title":"Sequence characteristics, subcellular localization, and substrate specificity of DYRK-Related kinases, a novel family of dual specificity protein kinases","volume":"273","author":"Becker","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2025.152166_bib11","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2024.2418470","article-title":"Discovering a novel dual specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A) inhibitor and its impact on tau phosphorylation and amyloid-\u03b2 formation","volume":"39","author":"Tu","year":"2024","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.bbrc.2025.152166_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1277537","article-title":"Insights from the protein interaction universe of the multifunctional \u201cGoldilocks\u201d kinase DYRK1A","volume":"11","author":"Ananthapadmanabhan","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bbrc.2025.152166_bib13","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.pharmthera.2018.09.010","article-title":"DYRK1A and cognition: a lifelong relationship","volume":"194","author":"Arbones","year":"2019","journal-title":"Pharmacol. Therapeut."},{"key":"10.1016\/j.bbrc.2025.152166_bib14","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.str.2013.03.012","article-title":"Structures of Down syndrome kinases, DYRKs, reveal mechanisms of kinase activation and substrate recognition","volume":"21","author":"Soundararajan","year":"2013","journal-title":"Structure"},{"key":"10.1016\/j.bbrc.2025.152166_bib15","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.nbd.2005.03.020","article-title":"Constitutive Dyrk1A is abnormally expressed in Alzheimer disease, Down syndrome, pick disease, and related transgenic models","volume":"20","author":"Ferrer","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbrc.2025.152166_bib16","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.gendis.2021.12.004","article-title":"New insights into the roles for DYRK family in mammalian development and congenital diseases","volume":"10","author":"Yoshida","year":"2023","journal-title":"Genes & Diseases"},{"key":"10.1016\/j.bbrc.2025.152166_bib17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/hmg\/ddl437","article-title":"The DYRK1A gene, encoded in chromosome 21 Down syndrome critical region, bridges between \u03b2-amyloid production and tau phosphorylation in Alzheimer disease","volume":"16","author":"Kimura","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2025.152166_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116233","article-title":"Dual-specificity tyrosine phosphorylation-regulated kinase 1A promotes the inclusion of amyloid precursor protein exon 7","volume":"224","author":"Chu","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbrc.2025.152166_bib19","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1159\/000092315","article-title":"APP processing and the APP-KPI domain involvement in the amyloid cascade","volume":"2","author":"Menendez-Gonzalez","year":"2006","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.bbrc.2025.152166_bib20","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/j.1471-4159.2007.05075.x","article-title":"Dual\u2010specificity tyrosine (Y)\u2010phosphorylation regulated kinase 1A\u2010mediated phosphorylation of amyloid precursor protein: evidence for a functional link between Down syndrome and Alzheimer's disease","volume":"104","author":"Ryoo","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbrc.2025.152166_bib21","article-title":"Truncated Dyrk1A aggravates neuronal apoptosis by inhibiting ASF\u2010mediated Bcl\u2010x exon 2b inclusion","volume":"30","author":"Zhang","year":"2024","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.bbrc.2025.152166_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2024.117925","article-title":"A review on synthetic inhibitors of dual-specific tyrosine phosphorylation-regulated kinase 1A (DYRK1A) for the treatment of Alzheimer's disease (AD)","author":"Gehlot","year":"2024","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bbrc.2025.152166_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1326-3-8","article-title":"Tau exon 10 alternative splicing and tauopathies","volume":"3","author":"Liu","year":"2008","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.bbrc.2025.152166_bib24","doi-asserted-by":"crossref","first-page":"28660","DOI":"10.1074\/jbc.M802645200","article-title":"Increased dosage of Dyrk1A alters alternative splicing factor (ASF)-regulated alternative splicing of Tau in Down Syndrome","volume":"283","author":"Shi","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2025.152166_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232112841","article-title":"Phosphorylated tau in Alzheimer's disease and other tauopathies","volume":"23","author":"Rawat","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2025.152166_bib26","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s40478-020-00967-w","article-title":"Tau Ser208 phosphorylation promotes aggregation and reveals neuropathologic diversity in Alzheimer's disease and other tauopathies","volume":"8","author":"Xia","year":"2020","journal-title":"Acta Neuropathologica Communications"},{"key":"10.1016\/j.bbrc.2025.152166_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.114062","article-title":"DYRK1A inhibitors for disease therapy: current status and perspectives","volume":"229","author":"Liu","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bbrc.2025.152166_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.130090","article-title":"Harnessing memantine in Alzheimer's disease therapy through inhibition of microtubule affinity-regulating kinase: mechanistic insights","volume":"262","author":"Anwar","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bbrc.2025.152166_bib29","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1089\/omi.2024.0128","article-title":"Enriching anticancer drug pipeline with potential inhibitors of cyclin-dependent kinase-8 identified from natural products","volume":"28","author":"Zehra","year":"2024","journal-title":"OMICS A J. Integr. Biol."},{"key":"10.1016\/j.bbrc.2025.152166_bib30","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1089\/omi.2024.0128","article-title":"Enriching anticancer drug pipeline with potential inhibitors of cyclin-dependent Kinase-8 identified from natural products","volume":"28","author":"Zehra","year":"2024","journal-title":"OMICS"},{"key":"10.1016\/j.bbrc.2025.152166_bib31","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1021\/acs.jnatprod.5b00947","article-title":"Feeling nature's PAINS: natural products, natural product drugs, and pan assay interference compounds (PAINS)","volume":"79","author":"Baell","year":"2016","journal-title":"Journal of natural products"},{"key":"10.1016\/j.bbrc.2025.152166_bib32","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","article-title":"Lead-and drug-like compounds: the rule-of-five revolution","volume":"1","author":"Lipinski","year":"2004","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.bbrc.2025.152166_bib33","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/bioinformatics\/16.8.747","article-title":"PASS: prediction of activity spectra for biologically active substances","volume":"16","author":"Lagunin","year":"2000","journal-title":"Bioinformatics"},{"key":"10.1016\/j.bbrc.2025.152166_bib34","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbaa279","article-title":"InstaDock: a single-click graphical user interface for molecular docking-based virtual high-throughput screening","volume":"22","author":"Mohammad","year":"2021","journal-title":"Briefings Bioinf."},{"key":"10.1016\/j.bbrc.2025.152166_bib35","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1093\/bioinformatics\/btaa849","article-title":"PyMod 3: a complete suite for structural bioinformatics in PyMOL","volume":"37","author":"Janson","year":"2021","journal-title":"Bioinformatics"},{"key":"10.1016\/j.bbrc.2025.152166_bib36","first-page":"82","article-title":"Pymol: an open-source molecular graphics tool, CCP4 Newsl","volume":"40","author":"DeLano","year":"2002","journal-title":"Protein Crystallogr."},{"key":"10.1016\/j.bbrc.2025.152166_bib37","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1021\/ci3001277","article-title":"ZINC: a free tool to discover chemistry for biology","volume":"52","author":"Irwin","year":"2012","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bbrc.2025.152166_bib38","doi-asserted-by":"crossref","first-page":"D506","DOI":"10.1093\/nar\/gky1049","article-title":"UniProt: a worldwide hub of protein knowledge","volume":"47","author":"Consortium","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbrc.2025.152166_bib39","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","article-title":"pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures","volume":"58","author":"Pires","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbrc.2025.152166_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.102070","article-title":"The blood-brain barrier, a key bridge to treat neurodegenerative diseases","author":"Hang","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.bbrc.2025.152166_bib41","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2025.152166_bib42","first-page":"gkae303","article-title":"ProTox 3.0: a webserver for the prediction of toxicity of chemicals","author":"Banerjee","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbrc.2025.152166_bib43","doi-asserted-by":"crossref","DOI":"10.1063\/5.0004608","article-title":"The ORCA quantum chemistry program package","volume":"152","author":"Neese","year":"2020","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.bbrc.2025.152166_bib44","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1758-2946-4-17","article-title":"Avogadro: an advanced semantic chemical editor, visualization, and analysis platform","volume":"4","author":"Hanwell","year":"2012","journal-title":"J Cheminform"},{"key":"10.1016\/j.bbrc.2025.152166_bib45","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/jcc.20291","article-title":"GROMACS: fast, flexible, and free","volume":"26","author":"Van Der Spoel","year":"2005","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bbrc.2025.152166_bib46","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1002\/jcc.23354","article-title":"CHARMM36 all\u2010atom additive protein force field: validation based on comparison to NMR data","volume":"34","author":"Huang","year":"2013","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bbrc.2025.152166_bib47","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.1021\/acs.jctc.1c00645","article-title":"gmx_MMPBSA: a new tool to perform end-state free energy calculations with GROMACS","volume":"17","author":"Vald\u00e9s-Tresanco","year":"2021","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.bbrc.2025.152166_bib48","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/ncomms1090","article-title":"Development of a novel selective inhibitor of the Down syndrome-related kinase Dyrk1A","volume":"1","author":"Ogawa","year":"2010","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2025.152166_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2024.1492847","article-title":"Identification of potential bioactive phytochemicals for the inhibition of platelet-derived growth factor receptor \u03b2: a structure-based approach for cancer therapy","volume":"11","author":"Habib","year":"2024","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.bbrc.2025.152166_bib50","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s00894-009-0454-9","article-title":"Solvent accessible surface area approximations for rapid and accurate protein structure prediction","volume":"15","author":"Durham","year":"2009","journal-title":"J. Mol. Model."},{"key":"10.1016\/j.bbrc.2025.152166_bib51","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.jmgm.2009.01.006","article-title":"Free-energy landscape, principal component analysis, and structural clustering to identify representative conformations from molecular dynamics simulations: the myoglobin case","volume":"27","author":"Papaleo","year":"2009","journal-title":"J. Mol. Graph. Model."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25008812?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25008812?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T14:53:44Z","timestamp":1762095224000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X25008812"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":51,"alternative-id":["S0006291X25008812"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.152166","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure-guided discovery of tau-phosphorylating kinase DYRK1A inhibitors for therapeutic targeting of neuroinflammatory diseases: Insights from microsecond MD simulation and MMPBSA analyses","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.152166","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152166"}}